doc_id,table_id,row_index,ColumnA,ColumnB,ColumnC,ColumnD
WHO_TB_handbook_module5_pediatrics_2022,Table 7.1.,1,Age,"Preferred first-line regimen, including initiation while on TB treatment",Alternative first-line regimen,Special circumstances a
WHO_TB_handbook_module5_pediatrics_2022,Table 7.1.,2,Neonates,"AZT + 3TC + RAL [ b ,k ]",AZT + 3TC + NVP [l],"AZT + 3TC + LPV/r [ c ,k ]"
WHO_TB_handbook_module5_pediatrics_2022,Table 7.1.,3,Children,"ABC + 3TC + DTG [ d ,k ]","ABC + 3TC + LPV/r [k] TAF + 3TC (or FTC) + DTG [ e ,l ]","ABC + 3TC + EFV (or NVP [l] ) ABC + 3TC + RAL [ f ,k ] AZT + 3TC + EFV [ g ] (or NVP [l] ) AZT + 3TC + LPV/r (or RAL) [k]"
WHO_TB_handbook_module5_pediatrics_2022,Table 7.1.,4,Adolescents,"TDF + 3TC (or FTC) + DTG [ h ,k ]",TDF + 3TC + EFV 400 mg [ i ],"TDF + 3TC (or FTC) + EFV 600 mg [ i ] AZT + 3TC + EFV 600 mg [ i ] TDF + 3TC (or FTC) + PI/r [ I,k ] TDF + 3TC (or FTC) + RAL [k] TAF [ j ] + 3TC (or FTC) + DTG [l] ABC + 3TC + DTG [ h ,k ]"